Avita Medical (ASX:AVH) said last week it tapped former Novartis (NYSE:NVS) global biz dev & licensing chief scientific officer Dr. Michael Perry as its new chief executive officer, replacing resigning CEO Adam Kelliher. Dr. Perry served as a non-exec director of Avita since Feb 2013, according to the company, and held positions with Novartis including chief scientific […]
Avalere Health
AngioDynamics adds two to executive team | Personnel Moves
AngioDynamics (NSDQ:ANGO) added two new VPs to its executive team.
The Albany, N.Y.-based device maker named Matthew Kapusta senior VP of business development and Donna Haire senior VP of regulatory, quality, clinical and medical affairs.